Selvaraj V, Alsamman M
Brown J Hosp Med. 2025; 2(1):39745.
PMID: 40046540
PMC: 11878822.
DOI: 10.56305/001c.39745.
Mullard R, Sheedlo M
mBio. 2024; 16(1):e0240524.
PMID: 39611841
PMC: 11708034.
DOI: 10.1128/mbio.02405-24.
Tsuge H, Habuka N, Yoshida T
Toxins (Basel). 2024; 16(7).
PMID: 39057953
PMC: 11281641.
DOI: 10.3390/toxins16070313.
Pourliotopoulou E, Karampatakis T, Kachrimanidou M
Microorganisms. 2024; 12(5).
PMID: 38792835
PMC: 11124097.
DOI: 10.3390/microorganisms12051004.
Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffre M
Clin Microbiol Rev. 2024; 37(2):e0013523.
PMID: 38421181
PMC: 11324037.
DOI: 10.1128/cmr.00135-23.
A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from .
Sapa D, Brosse A, Coullon H, Pean de Ponfilly G, Candela T, Monnier A
Toxins (Basel). 2024; 16(1).
PMID: 38251254
PMC: 10821508.
DOI: 10.3390/toxins16010038.
A Colonic Organoid Model Challenged with the Large Toxins of TcdA and TcdB Exhibit Deregulated Tight Junction Proteins.
Schneemann M, Heils L, Moos V, Weiss F, Krug S, Weiner J
Toxins (Basel). 2023; 15(11).
PMID: 37999506
PMC: 10674794.
DOI: 10.3390/toxins15110643.
secretome suppresses virulence gene expression of in a bile acid-independent manner.
Saenz C, Fang Q, Gnanasekaran T, Trammell S, Buijink J, Pisano P
Microbiol Spectr. 2023; :e0393322.
PMID: 37750706
PMC: 10581174.
DOI: 10.1128/spectrum.03933-22.
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen.
Al-Zahrani I
Saudi Med J. 2023; 44(9):825-835.
PMID: 37717961
PMC: 10505283.
DOI: 10.15537/smj.2023.44.9.20230216.
Intestinal bile acids provide a surmountable barrier against TcdB-induced disease pathogenesis.
Icho S, Ward J, Tam J, Kociolek L, Theriot C, Melnyk R
Proc Natl Acad Sci U S A. 2023; 120(19):e2301252120.
PMID: 37126691
PMC: 10175849.
DOI: 10.1073/pnas.2301252120.
Anaerobes and Toxins, a Tradition of the Institut Pasteur.
Popoff M, Legout S
Toxins (Basel). 2023; 15(1).
PMID: 36668863
PMC: 9861305.
DOI: 10.3390/toxins15010043.
Requirement of Peptidyl-Prolyl Cis/Trans isomerases and chaperones for cellular uptake of bacterial AB-type toxins.
Ernst K
Front Cell Infect Microbiol. 2022; 12:938015.
PMID: 35992160
PMC: 9387773.
DOI: 10.3389/fcimb.2022.938015.
The Pore-Forming Subunit C2IIa of the Binary C2 Toxin Reduces the Chemotactic Translocation of Human Polymorphonuclear Leukocytes.
Eisele J, Schreiner S, Borho J, Fischer S, Heber S, Endres S
Front Pharmacol. 2022; 13:810611.
PMID: 35222028
PMC: 8881014.
DOI: 10.3389/fphar.2022.810611.
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.
Kordus S, Thomas A, Lacy D
Nat Rev Microbiol. 2021; 20(5):285-298.
PMID: 34837014
PMC: 9018519.
DOI: 10.1038/s41579-021-00660-2.
Epidemiology and virulence-associated genes of isolates and factors associated with toxin EIA results at a university hospital in Japan.
Okada Y, Yagihara Y, Wakabayashi Y, Igawa G, Saito R, Higurashi Y
Access Microbiol. 2021; 2(2):acmi000086.
PMID: 34568752
PMC: 8459100.
DOI: 10.1099/acmi.0.000086.
as a Dynamic Vehicle for the Dissemination of Antimicrobial-Resistance Determinants: Review and In Silico Analysis.
Kartalidis P, Skoulakis A, Tsilipounidaki K, Florou Z, Petinaki E, Fthenakis G
Microorganisms. 2021; 9(7).
PMID: 34202117
PMC: 8307371.
DOI: 10.3390/microorganisms9071383.
Characterization and Pharmacological Inhibition of the Pore-Forming CDTb Toxin.
Ernst K, Landenberger M, Nieland J, Norgaard K, Frick M, Fois G
Toxins (Basel). 2021; 13(6).
PMID: 34071730
PMC: 8226936.
DOI: 10.3390/toxins13060390.
Complete genome sequence of the newly discovered temperate Clostridioides difficile bacteriophage phiCDKH01 of the family Siphoviridae.
Hinc K, Kabala M, Iwanicki A, Martirosian G, Negri A, Obuchowski M
Arch Virol. 2021; 166(8):2305-2310.
PMID: 34014385
PMC: 8270841.
DOI: 10.1007/s00705-021-05092-0.
The Importance of Therapeutically Targeting the Binary Toxin from .
Abeyawardhane D, Godoy-Ruiz R, Adipietro K, Varney K, Rustandi R, Pozharski E
Int J Mol Sci. 2021; 22(6).
PMID: 33805767
PMC: 8001090.
DOI: 10.3390/ijms22062926.
Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection.
Littmann E, Lee J, Denny J, Alam Z, Maslanka J, Zarin I
Nat Commun. 2021; 12(1):755.
PMID: 33531483
PMC: 7854624.
DOI: 10.1038/s41467-020-20793-x.